Adenosine is found throughout the nervous system, and its interaction with specific adenosine receptors modulates ongoing neuronal activity in many brain regions. As the core molecule of adenosine triphosphate (ATP), and a component of the overall cellular energy charge, adenosine provides a unique cellular link between energy demand and brain function. The specific inhibitory influence of the adenosine A1 receptor subtype reduces activity and helps neurons survive a short-term compromised energy supply, such as during insufficient oxygen or glucose. Its modulation of physiology and protection against pathology make adenosine a coveted therapeutic target for disorders as diverse as pain, Parkinson's disease, stroke, epilepsy, and sleep disorders. Accumulated research shows that adenosine levels are altered significantly by changes in temperature, pH, oxygen and glucose. The objective of this proposal is to elucidate the relationship between adenosine and these physiologically-relevant variables to inform and benefit both basic research and clinical conditions.
The specific aims outlined herein quantify the influence of adenosine across the typical range of recording temperatures in the hippocampal slice, and systematically examine the effect(s) of reducing available oxygen and/or glucose using a combination of electrophysiology, pharmacology and genetically modified mice. Beyond the clinical significance, the proposed studies are relevant to understanding features of the model systems we use in neuroscience, and they represent a succinct set of fundamental research experiments useful as a training platform for young scientists. Ultimately, understanding the regulation of endogenous adenosine, its influence on widely used model systems, and its functional consequences during pathological conditions will enable us to explore and enhance its therapeutic possibilities in situations as diverse as stroke, epilepsy and spinal cord injury. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
3R15NS061290-01S1
Application #
7669851
Study Section
Neurotransporters, Receptors, and Calcium Signaling Study Section (NTRC)
Program Officer
Stewart, Randall R
Project Start
2007-12-15
Project End
2009-11-30
Budget Start
2007-12-15
Budget End
2009-11-30
Support Year
1
Fiscal Year
2008
Total Cost
$38,000
Indirect Cost
Name
Trinity College
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
069259950
City
Hartford
State
CT
Country
United States
Zip Code
06106
Masino, S A; Kawamura Jr, M; Ruskin, D N et al. (2012) Purines and neuronal excitability: links to the ketogenic diet. Epilepsy Res 100:229-38
Kawamura Jr, Masahito; Ruskin, David N; Masino, Susan A (2010) Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels. J Neurosci 30:3886-95
Hoffman, Alexander F; Laaris, Nora; Kawamura, Masahito et al. (2010) Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J Neurosci 30:545-55
Masino, Susan A; Kawamura Jr, Masahito; Ruskin, David N et al. (2010) Purines and the Anti-Epileptic Actions of Ketogenic Diets. Open Neurosci J 4:58-63
Ruskin, David N; Kawamura, Masahito; Masino, Susan A (2009) Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS One 4:e8349
Dulla, Chris G; Frenguelli, Bruno G; Staley, Kevin J et al. (2009) Intracellular acidification causes adenosine release during states of hyperexcitability in the hippocampus. J Neurophysiol 102:1984-93
Masino, Susan A; Geiger, Jonathan D (2009) The ketogenic diet and epilepsy: is adenosine the missing link? Epilepsia 50:332-3
Masino, S A; Kawamura, M; Wasser, C D et al. (2009) Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity. Curr Neuropharmacol 7:257-68
Masino, Susan A; Geiger, Jonathan D (2008) Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci 31:273-8